6 January, 2021

SYMPOSIA_17th International Congress of Endocrinology jointly with the 15th Annual Conference of Chinese Society of Endocrinology


Pituitary Tumorigenesis
Friday, September 2, 2016: 10:15-11:45
Chair:Hermann Müller, Pediatrics and head of the Department of Pediatric Hematology and Oncology; Klinikum Oldenburg, Germany
10:15-10:45    Natural history of non-functional pituitary adenoma
Warrick Inder, Department of Endocrinology and Diabetes, Princess Alexandra Hospital, Australia
10:45-11:15    Differentiation of pluripotent stem cells into hypothalamic and pituitary cells
Hidetaka Suga, Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Japan
11:15-11:45    Insights from molecular pathology
Silvia Asa, University Health Network, University of Toronto, Canada

Primary Aldosteronism
Friday, September 2, 2016: 10:15-11:45
Chair:Fumitoshi Satoh, Division of Clinical Hypertension, Endocrinology and Metabolism, Tohoku University Graduate School of Medicine, Japan
10:15-10:45    New genes for a 50-year old disease
Maria-Christina  Zennaro, 1INSERM, UMRS_970, Paris Cardiovascular Research Center, Paris, France
10:45-11:15    Genetics of primary hyperaldosteronism. Alternative: Prevalence of and risk factors for primary Weiqing Wang, Shanghai Jiaotong University,
School of Medicine, Ruijin Hospital, China
11:15-11:45    Implications for essential hypertension
Richard Auchus, University of Michigan, USA

Graves Orbitopathy
Friday, September 2, 2016: 10:15-11:45
Chair: To be Confirmed
10:15-10:45    Clinical management of GO patients: Experiences from EUGOGO
Simon Pearce, Newcastle University, UK
10:45-11:15    Novel approaches in detection of auto-antibodies in GO

Lutz Schomburg, Charité Universitätsmedizin Berlin, Germany
11:15-11:45    Therapy of graves orbitopathy
Wilmar M. Wiersinga, Dept. of Endocrinology & Metabolism, Academic Medical Center, University of Amsterdam

Hypothalamus and Energy Homeostasis
Program: Symposia
Friday, September 2, 2016: 10:15-11:45
Chair: Jon Levine, USA
10:15-10:45    Hypothalamic
inflammation in obesity and diabetes
Chun-Xia Yi,
Department of Endocrinology and Metabolism, Academic Medical Center (AMC),
University of Amsterdam, The Netherlands

10:45-11:15    Central Sirt1 regulates energy balance via the melanocortin system
Patricia Joseph-Bravo, Universidad Nacional Autónoma de México. Mexico
11:15-11:45    Hunger-driving hypothalamic circuits
Kevin Williams,
Southwestern University, USA

Diabetes and Bone
Friday, September 2, 2016: 10:15-11:45
Chair: Delores Shoback, USA
10:15-10:45    Assessing fracture risk in diabetes
Anna Schwartz, University of California, San Francisco, USA
10:45-11:15    Effects of advanced glycation products on bone
Antonio  McCarthy, Laboratorio de Osteopatías y Metabolismo Mineral (LIOMM) Universidad Nacional de La Plata, Argentina
11:15-11:45    Effect of diabetes drugs on bone metabolism
Lorenz Hofbauer,
Division of Endocrinology, Diabetes and Metabolic Bone Diseases Technical University of Dresden

Vitamin D – Myths and Facts
Program: Symposia
Friday, September 2, 2016: 10:15-11:45
Roger Bouillon, Belgium
10:15-10:45    Epidemiology of vitamin D on health outcomes
Robert Scragg, School of Population Health, University of Auckland, New Zealand
10:45-11:15    Does vitamin D treatment improve health outcomes – data from trials
Rolf Jorde,
UiT – The Arctic University of Norway, Norway
11:15-11:45     Reconciling observational studies of vitamin D with randomized control trials – Why the Difference?
Kevin Cashman, University College Cork, Ireland

Neuroestrogens and Brain Function
Friday, September 2, 2016: 10:15-11:45
Chair: Margaret McCarthy, USA
10:15-10:45    Estrogen rapidly modulates spinogenesis in the hippocampus
Suguru Kawato, Tokyo University, Japan
10:45-11:15    Neuroestrogens and the regulation of GnRH release
Ei Terasawa, University of Wisconsin-Madison, USA
11:15-11:45    Role of neuroestrogens in the regulation of sexual behavior
Charlotte Cornil, Université de Liège, Belgium

The Timing of Puberty:  Neuroendocrine and Genetic Factors
Friday, September 2, 2016: 10:15-11:45
Yiming Mu, Department of Endocrinology, Chinese PLA General Hospital, Beijing, China
10:15-10:45    The integrated tachykinin-kisspeptin neuronal system and puberty
Ursula Kaiser, Brigham and Women’s Hospital, Harvard Medical School, USA
10:45-11:15 Using Genetic Approaches in a Rare Human Disease Model to Define the Neuroendocrine Control of Human Reproduction
Stephanie Seminara, Harvard, USA
11:15-11:45    MicroRNAs, GnRH release, and GnRH neuronal development
Vincent Prevot, Inserm, University of Lille, France

Prolactin: Whats New?
Friday, September 2, 2016: 10:15-11:45
Maria Fleseriu, Oregon Health Science University, Northwest Pituitary Center, USA
10:15-10:45    Prolactin and cancer
Vincent Goffin, University Paris Descartes and Inserm U1151, France
10:45-11:15    Prolactinomas and MEN1
Marta Korbonits, Barts and the London School of Medicine, UK
11:15-11:45    Treatment of prolactinomas: Whats new?
Xueyan Wu, China

Diabetic Complications
Friday, September 2, 2016: 10:15-11:45
Urd Kielgast, Køge University Hospital, Denmark
10:15-10:45    Epigenetics in metabolic kidney disease
Hiroshi Itoh, Keio University, Japan
10:45-11:15    Insulin Pump therapy and cardiovascular mortality
Isabelle Steineck, Department of Endocrinology of Copenhagen University, Hvidovre Hospital, Sweden
11:15-11:45    Rising tide of early onset diabetes in Asia – Clinical pathophysiological and etiological characteristics and  management  challenges
Linong Ji, Peking University Peoples Hospital, China

Leave a Reply

Your email address will not be published. Required fields are marked *